Literature DB >> 21442314

PTP1B expression contributes to gastric cancer progression.

Jinguo Wang1, Bingya Liu, Xuehua Chen, Liping Su, Pei Wu, Jian Wu, Zhenggang Zhu.   

Abstract

Protein tyrosine phosphatase 1B (PTP1B), a member of the superfamily of protein tyrosine phosphatases, has been implicated in cancer pathogenesis. However, the role of PTP1B in the development of gastric cancer is unclear. The purpose of this study was to clarify the expression pattern and role of PTP1B in the gastric cancer. The expression of PTP1B in gastric cancer tissues was determined by immunohistochemical staining. Cell growth assay, soft agar colony formation assay, and tumorigenicity assay were used for examining proliferation, colony formation, and in vivo tumorigenesis of gastric cancer cells. The total levels and phosphorylated levels of Akt, extracellular signal-regulated kinase (Erk1/2), focal adhesion kinase (FAK), and Src were examined by western blotting, respectively. PTP1B was overexpressed in gastric cancer tissues (65/80) and correlated with tumor metastasis and tumor-node-metastasis stage. Overexpression of PTP1B promoted the proliferation and in vivo tumorigenesis of MKN45 cells and also increased the phosphorylation levels of Akt, Erk1/2, and FAK and the activity of Src. These results were conformed by knockdown of PTP1B in MKN28 cells. Therefore, our study suggested that PTP1B expression might play an important role in the development of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442314     DOI: 10.1007/s12032-011-9911-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  30 in total

Review 1.  PTP1B and TC-PTP: regulators of transformation and tumorigenesis.

Authors:  Matthew Stuible; Karen M Doody; Michel L Tremblay
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

2.  In vitro and in vivo evidence of metallopanstimulin-1 in gastric cancer progression and tumorigenicity.

Authors:  Yun-Wei Wang; Ying Qu; Jian-Fang Li; Xue-Hua Chen; Bing-Ya Liu; Qin-Long Gu; Zheng-Gang Zhu
Journal:  Clin Cancer Res       Date:  2006-08-15       Impact factor: 12.531

3.  Suppression of PTP1B in gastric cancer cells in vitro induces a change in the genome-wide expression profile and inhibits gastric cancer cell growth.

Authors:  Jinguo Wang; Xuehua Chen; Bingya Liu; Zhenggang Zhu
Journal:  Cell Biol Int       Date:  2010-07       Impact factor: 3.612

4.  Purification of the major protein-tyrosine-phosphatases of human placenta.

Authors:  N K Tonks; C D Diltz; E H Fischer
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

5.  Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.

Authors:  Nadia Dubé; Annie Bourdeau; Krista M Heinonen; Alan Cheng; Ailsa Lee Loy; Michel L Tremblay
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

6.  Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas.

Authors:  J R Wiener; J A Hurteau; B J Kerns; R S Whitaker; M R Conaway; A Berchuck; R C Bast
Journal:  Am J Obstet Gynecol       Date:  1994-04       Impact factor: 8.661

Review 7.  The epidemiology of gastric cancer.

Authors:  David M Roder
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

8.  Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.

Authors:  Shui Ping Tu; Xiao Hua Jiang; Marie C M Lin; Jian Tao Cui; Yi Yang; Ching Tung Lum; Bing Zou; Yan Bo Zhu; Shi Hu Jiang; Wai Man Wong; Annie On-On Chan; Man Fung Yuen; Shiu Kum Lam; Hsiang Fu Kung; Benjamin Chun-Yu Wong
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

9.  Activation of Src by protein tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells.

Authors:  Luis E Arias-Romero; Sayanti Saha; Olga Villamar-Cruz; Shu-Chin Yip; Stephen P Ethier; Zhong-Yin Zhang; Jonathan Chernoff
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

10.  Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.

Authors:  Sanjay Sachdev; Yahao Bu; Irwin H Gelman
Journal:  BMC Cancer       Date:  2009-01-12       Impact factor: 4.430

View more
  15 in total

Review 1.  Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.

Authors:  Lakshmi Reddy Bollu; Abhijit Mazumdar; Michelle I Savage; Powel H Brown
Journal:  Clin Cancer Res       Date:  2017-01-13       Impact factor: 12.531

2.  Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis.

Authors:  Queting Chen; Yong Li; Zhong Li; Qun Zhao; Liqiao Fan
Journal:  J Mol Histol       Date:  2013-08-29       Impact factor: 2.611

3.  PTP1B is an androgen receptor-regulated phosphatase that promotes the progression of prostate cancer.

Authors:  Laurent Lessard; David P Labbé; Geneviève Deblois; Louis R Bégin; Serge Hardy; Anne-Marie Mes-Masson; Fred Saad; Lloyd C Trotman; Vincent Giguère; Michel L Tremblay
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

4.  Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer.

Authors:  Shi-Chong Liao; Jin-Xin Li; Li Yu; Sheng-Rong Sun
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

5.  Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients.

Authors:  Na Wang; Junjun She; Wei Liu; Jing Shi; Qi Yang; Bingyin Shi; Peng Hou
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma.

Authors:  Mariana Tannús Ruckert; Pamela Viani de Andrade; Verena Silva Santos; Vanessa Silva Silveira
Journal:  Cell Mol Life Sci       Date:  2019-04-13       Impact factor: 9.207

7.  Targeting the disordered C terminus of PTP1B with an allosteric inhibitor.

Authors:  Navasona Krishnan; Dorothy Koveal; Daniel H Miller; Bin Xue; Sai Dipikaa Akshinthala; Jaka Kragelj; Malene Ringkjøbing Jensen; Carla-Maria Gauss; Rebecca Page; Martin Blackledge; Senthil K Muthuswamy; Wolfgang Peti; Nicholas K Tonks
Journal:  Nat Chem Biol       Date:  2014-05-20       Impact factor: 15.040

8.  miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma.

Authors:  Qian Yang; Lunli Zhang; Yuanbin Zhong; Lingling Lai; Xiaopeng Li
Journal:  Biosci Rep       Date:  2019-05-15       Impact factor: 3.840

9.  Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome.

Authors:  Elmer Hoekstra; Asha M Das; Marloes Swets; Wanlu Cao; C Janneke van der Woude; Marco J Bruno; Maikel P Peppelenbosch; Peter J K Kuppen; Timo L M Ten Hagen; Gwenny M Fuhler
Journal:  Oncotarget       Date:  2016-04-19

10.  miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B.

Authors:  Feng Sun; Mengchao Yu; Jing Yu; Zhijian Liu; Xinyan Zhou; Yanqing Liu; Xiaolong Ge; Haidong Gao; Mei Li; Xiaohong Jiang; Song Liu; Xi Chen; Wenxian Guan
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.